Stay updated with breaking news from Mark Corbae. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company focused on oncology therapeutics, announced today the peer-reviewed...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company focused on oncology therapeutics, today announced that the Company has...
/PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics," stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics,...
Phosplatin Therapeutics Appoints Lorenzo Galluzzi, PhD, a Pioneer in Immunogenic Cell Death Research, to Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace